Related Experiment Video
Updated: Jun 20, 2026
10:56
A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes
Published on: September 15, 2018
Familial hypercholesterolaemia: different perspectives
Jane L Jones1, Edin Lakasing, Stefanos Archontakis
1Royal Brompton and Harefield NHS Trust, Middlesex.
Nursing Standard (Royal College of Nursing (Great Britain) : 1987)
|September 10, 2009
Summary
Familial hypercholesterolaemia is an inherited condition causing high blood cholesterol and early heart disease risk. This review covers its features, pathology, epidemiology, and management, highlighting it as an underdiagnosed condition.
Area of Science:
- Cardiovascular Medicine
- Genetics
- Metabolic Disorders
Background:
- Familial hypercholesterolaemia (FH) is a genetic disorder.
- Characterized by significantly elevated low-density lipoprotein cholesterol levels.
- Leads to a substantially increased risk of premature atherosclerotic cardiovascular disease.
Purpose of the Study:
- To provide a comprehensive overview of familial hypercholesterolaemia.
- To review the clinical presentation, underlying pathology, and epidemiological data.
- To discuss current clinical management strategies for FH.
Main Methods:
- Literature review of clinical features, pathology, and epidemiology.
- Analysis of diagnostic criteria and management guidelines.
- Synthesis of current research on FH.
Main Results:
- FH presents with characteristic clinical features, including xanthomas and premature cardiovascular events.
- Pathology involves genetic defects leading to impaired LDL cholesterol clearance.
- Epidemiological data suggests FH is underdiagnosed globally.
Conclusions:
- Early diagnosis and effective management of FH are crucial to reduce cardiovascular risk.
- Multidisciplinary approaches are essential for optimal patient care.
- Increased awareness and screening are needed to address the underdiagnosis of FH.
Related Concept Videos
01:29Cholesterol: Significance and Regulation
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:30Atherosclerosis I: Introduction
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
01:24Overview of Lipid Metabolism
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...